Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Premature recognition and clearance of nanoparticulate imaging and therapeutic agents by macrophages in the tissues can dramatically reduce both the nanoparticle half-life and delivery to the diseased tissue. Grafting nanoparticles with hydrogels prevents nanoparticulate recognition by liver and spleen macrophages and greatly prolongs circulation times in vivo. Understanding the mechanisms by which hydrogels achieve this "stealth" effect has implications for the design of long-circulating nanoparticles. Thus, the role of plasma protein absorption in the hydrogel effect is not yet understood. Short-circulating dextran-coated iron oxide nanoparticles could be converted into stealth hydrogel nanoparticles by cross-linking with 1-chloro-2,3-epoxypropane. We show that hydrogelation did not affect the size, shape and zeta potential, but completely prevented the recognition and clearance by liver macrophages in vivo. Hydrogelation decreased the number of hydroxyl groups on the nanoparticle surface and reduced the binding of the anti-dextran antibody. At the same time, hydrogelation did not reduce the absorption of cationic proteins on the nanoparticle surface. Specifically, there was no effect on the binding of kininogen, histidine-rich glycoprotein, and protamine sulfate to the anionic nanoparticle surface. In addition, hydrogelation did not prevent activation of plasma kallikrein on the metal oxide surface. These data suggest that (a) a stealth hydrogel coating does not mask charge interactions with iron oxide surface and (b) the total blockade of plasma protein absorption is not required for maintaining iron oxide nanoparticles' long-circulating stealth properties. These data illustrate a novel, clinically promising property of long-circulating stealth nanoparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, some studies revealed that dextran as a shielding agent for nanoparticles displayed anti-fouling effects and prolonged circulation in animal models [96, 97].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [96]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Iron oxide MR contrast agents for molecular and cellular imaging
Bulte, J. W. M., & Kraitchman, D. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.924 · Cited by 1,500
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,324
Research works printed but not linked: 2
- Simmons G. W., 1987, Langmuir, 91, 1143
- Kamps J. A., 1998, Adv. Drug Delivery Rev., 32, 81
Cited by
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
Magnetic iron oxide nanoparticles for brain imaging and drug delivery
Qiao, R., Fu, C., Forgham, H., Javed, I., Huang, X., Zhu, J., Whittaker, A. K., & Davis, T. P. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114822 · Cited by 245
Pharmacokinetics of magnetic iron oxide nanoparticles for medical applications
Nowak-Jary, J., & Machnicka, B. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01510-w · Cited by 161
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
La-Beck, N. M., Islam, M. R., & Markiewski, M. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603039 · Cited by 174
From structure to function: A comprehensive overview of polysaccharide roles and applications
Xu, B., Li, S., Ding, W., Zhang, C., Rehman, M. U., Tareen, M. F., Wang, L., & Huang, S. (2024) · Food Frontiers · doi:10.1002/fft2.490 · Cited by 115
“Polysaccharides play a crucial role in extending the circulating half-life of drugs, reducing total doses, and enhancing drug bioavailability (Karmali et al., 2012).”
Banda, N. K., Mehta, G., Chao, Y., Wang, G., Inturi, S., Fossati-Jimack, L., Botto, M., Wu, L., Moghimi, S. M., & Simberg, D. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0064-2 · Cited by 94
“Complement products on the surface of Feridex and SPIO nanoworms.”
BackgroundMethodInfluentialSelf-citationInturi, S., Wang, G., Chen, F., Banda, N. K., Holers, V. M., Wu, L., Moghimi, S. M., & Simberg, D. (2015) · ACS Nano · doi:10.1021/acsnano.5b05061 · Cited by 95
“leads to hydrogel coated cross-linked nanoworms (CLNWs, Figure 7A).(26,27,44) Previouslywedemonstrated that cross-linking blocks the lectin pathway activation in mouse serumand consequently decreases complement C3 opsonization(28) and decreases macrophage recognition in mice.”
Self-citationFedeli, C., Segat, D., Tavano, R., Bubacco, L., Franceschi, G. D., de Laureto, P. P., Lubian, E., Selvestrel, F., Mancin, F., & Papini, E. (2015) · Nanoscale · doi:10.1039/c5nr05290d · Cited by 80
Wang, G., Inturi, S., Serkova, N. J., Merkulov, S., McCrae, K. R., Russek, S. E., Banda, N. K., & Simberg, D. (2014) · ACS Nano · doi:10.1021/nn505126b · Cited by 73
“crystalline core on SPIO and CLIO and not to the nanoworm coating.(32,46) There was a 50% decrease in the binding of D5 and 70% decrease in the binding of kininogen (Figure 4C and D, respectively) to CLIO-H(10N).”
BackgroundSelf-citationDirect Recognition of Superparamagnetic Nanocrystals by Macrophage Scavenger Receptor SR-AI
Chao, Y. S., Karmali, P. P., Mukthavaram, R., Kesari, S., Kouznetsova, V. L., Tsigelny, I. F., & Simberg, D. (2013) · ACS Nano · doi:10.1021/nn400769e · Cited by 69
“dependent mechanism (complement, IgM, fibronectin).(2,5,6) The same mechanisms ap-”
BackgroundMethodSelf-citationMüller, W. E. G., Wang, X., Proksch, P., Perry, C. C., Osinga, R., Gardères, J., & Schröder, H. C. (2013) · Marine Biotechnology · doi:10.1007/s10126-013-9497-0 · Cited by 66
“Since then, until 10 years ago, 70 % of the vessels of world fleet had been protected with TBT-based coatings that turned out to be economically beneficial (Karmali et al. 2012).”
BackgroundBamberger, D., Hobernik, D., Konhäuser, M., Bros, M., & Wich, P. R. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00507 · Cited by 63
Wang, G., Chen, F., Banda, N. K., Holers, V. M., Wu, L., Moghimi, S. M., & Simberg, D. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00418 · Cited by 61
Self-citationEngineered Magnetic Nanoparticles for Biomedical Applications
Canfarotta, F., & Piletsky, S. A. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300141 · Cited by 60
Vorup‐Jensen, T. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.003 · Cited by 57
Grudziński, I. P., Bystrzejewski, M., Cywińska, M. A., Kośmider, A., Popławska, M., Cieszanowski, A., & Ostrowska, A. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1835-7 · Cited by 52
“…hydrophilic surfaces of nanoparticles, such as dextran, polyethylene glycol, polyethylene oxide, poloxamers, polysorbates, and polyoxamines provide a dynamic ‘‘cloud’’ of hydrophilic and neutral chains at the nanoparticle surface (Chiappetta et al. 2011; Gillich et al. 2011; Karmali et al. 2012).”
BackgroundBelanova, A. A., Gavalas, N. G., Makarenko, Y. M., Belousova, M. M., Soldatov, A. V., & Zolotukhin, P. V. (2018) · Oncology Research and Treatment · doi:10.1159/000485020 · Cited by 52
Externally addressable hydrogel nanocomposites for biomedical applications
Campbell, S., & Hoare, T. R. (2014) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2013.12.003 · Cited by 53
Fathy, M. M., Fahmy, H. M., Balah, A. M. M., Mohamed, F. F., & Elshemey, W. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116787 · Cited by 50
Bevilacqua, P., Nuzzo, S., Torino, E., Condorelli, G., Salvatore, M., & Grimaldi, A. (2021) · Nanomaterials · doi:10.3390/nano11030780 · Cited by 53
“7, D556, Daoy, U87MG, MDA-MB-231, MCF7 and A549 - Theranostic Tu et al. 2016 [20] Silicon Quantum DotNanoparticles (SiQD-NPs) PEG and Bovine Serum Albumin (BSA) CHO, SKOV3 - OI SuàrezGarzìa 2021 [21] Metal-phenolic NPs (MPS) PEG CT26, HeLa, 3T3 bearing CT26 tumour-bearing mice SPECT/PET Li et al. 2019 [22] Gold NPs(Au…”
BackgroundInfluentialIsolation of Rare Tumor Cells from Blood Cells with Buoyant Immuno-Microbubbles
Shi, G., Cui, W., Benchimol, M. J., Liu, Y.-T., Mattrey, R. F., Mukthavaram, R., Kesari, S., Esener, S. C., & Simberg, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058017 · Cited by 41
“Crosslinked iron oxide nanoparticles were prepared as described [23].”
MethodSelf-citationBaiu, D. C., Artz, N. S., McElreath, M. R., Menapace, B. D., Hernando, D., Reeder, S. B., Grüttner, C., & Otto, M. (2015) · Nanomedicine · doi:10.2217/nnm.15.138 · Cited by 22
Müller, W. E. G., Wang, X., Guo, Y., & Schröder, H. C. (2012) · Marine Drugs · doi:10.3390/md10112369 · Cited by 17
“Unfortunately, TBT-SPC paints adversely affect the environment.”
BackgroundInfluentialRobinson, K. J., Voelcker, N. H., & Thissen, H. W. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.037 · Cited by 18
Selectively self-assembling graphene nanoribbons with shaped iron oxide nanoparticles
Li, H., Melnyczuk, J. M., Lewis, L. I., Palchoudhury, S., Wu, J., Nagappan, P., Harruna, I. I., & Wang, X. (2014) · RSC Advances · doi:10.1039/c4ra05872k · Cited by 9
Iron Oxide Magnetic Nanoparticles (NPs) Tailored for Biomedical Applications
Zoppellaro, G. (2020) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-030-39923-8_2 · Cited by 8
Sugiura, K., Hata, Y., Ishibashi, K., Sawada, T., TANAKA, H. L., Watanabe, G., & Serizawa, T. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01372k · Cited by 6
Palchoudhury, S., Hyder, F., Vanderlick, T. K., & Geerts, N. (2013) · Particulate Science And Technology · doi:10.1080/02726351.2013.850460 · Cited by 6
Radioimmunotherapy and Hematopoietic Cell Transplantation
Pagel, J. M., & Gopal, A. K. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch23 · Cited by 3
The Use of Nanomaterials in Activating the Complement System
Chavda, V. P., Gholap, A. D., Bezbaruah, R., Balar, P. C., Rynjah, D., Uhal, B. D., & Uversky, V. N. (2024) · Springer eBooks · doi:10.1007/978-981-96-0397-8_6 · Cited by 1
Biomedical antifouling polymer nanocomposites
Parambath, J. B. M., Arooj, M., & Mohamed, A. A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88524-9.00006-1 · Cited by 1
Functionalized magnetic nanosystems for in-vivo diagnosis and therapy
Dutta, G., Dastidar, D. G., Paul, P., Jana, B., Chinnaiyan, S. K., & Sugumaran, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19012-4.00013-8 · Cited by 1
Selection of Conditioning Regimen and Challenges with Different Types of T-Cell Depletion Methods
Abutalib, S. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.028
Controversies in Radioimmunotherapy for Hematopoietic Cell Transplantation
Buckley, S. A., & Pagel, J. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.029
Suleimenov, I. E., Dyussova, R., Shaltykova, D. B., Atasoy, E., Seitenova, G. Z., & Копишев, Э. Е. (2025) · Polymers · doi:10.3390/polym17111441
Metadata
- Authors
- Karmali, P. P., Chao, Y., Park, J.-H., Sailor, M. J., Ruoslahti, E., Esener, S. C., & Simberg, D.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of California San Diego (US)
- Korea Advanced Institute of Science and Technology (KR)
- University of California, Santa Barbara (US)
- Corresponding author
- Simberg, Dmitri
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-02-02
- Volume
- 9
- Issue
- 3
- Pages
- 539-545
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- PMC
- PMC3295900
- OpenAlex
- W2156802864
- Cited by
- 36
- References
- 39
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 2
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- University of California, San Diego
- National Cancer Institute (R21CA137721, P30-CA-23100, U54CA119335, R21CA164880, P30CA023100)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- hydrogelation, antifouling, long-circulating nanoparticles, macrophage recognition, plasma protein adsorption, surface charge, anti-dextran antibodies, kallikrein activation, nanoparticle clearance
- MeSH terms
- Animals, Dextrans, Female, Ferric Compounds, Iron-Dextran Complex, Kininogens, Mice, Inbred C57BL, Protein Binding, Hydrogel, Polyethylene Glycol Dimethacrylate, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.